Efficacy of Oral AHCC Supplementation in Female Breast Cancer Patients Undergoing Anthracycline-based Anticancer Drug as Adjuvant Chemotherapy: Randomized, Double-blind, Placebo controlled, Confirmatory Study - Efficacy of AHCC in Breast Cancer Patients Undergoing Anthracycline-based Adjuvant Chemotherapy: Placebo controlled, Confirmatory Study

on-Profit Organization JORTC0 个研究点目标入组 42 人开始时间: 2018年2月20日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Previous treatment with chemotherapy 2. Previous treatment with radiation simultaneously with chemotherapy or received <= 4 weeks prior to enrollment 3. Currently taking dietary supplements derived from basidiomycetes (such as agaricus or health food derived from a mushroom) (allowed if discontinued for more than 7 days before the start of the study) 4. Currently taking dietary supplements except for multivitamins (allowed if discontinued for more than 7 days before the start of the study) 5. Allergy for a health food derived from a mushroom or basidiomycetes 6. Pregnant or breastfeeding 7. Immune deficiency 8. Enrollment in other clinical trials 9. Cognitive disorder prior to enrollment 10. Psychiatric disorder that may affect data sampling 11. Unable to communicate verbally 12. Uncapable of oral ingestion 13. Malabsorption syndrome 14. Past history of gastrectomy 15. Active gastrointestinal bleeding unrelated with cancer 16. Investigator considers that the patient is not suitable for the study

发起方

on-Profit Organization JORTC